James T. Dalton
From Wikipedia the free encyclopedia
James Dalton | |
|---|---|
| Born | 1963 (age 60–61) |
| Academic background | |
| Education | BSc., University of Cincinnati PhD., pharmaceutics and pharmaceutical chemistry, Ohio State University |
| Thesis | Pharmacokinetic and pharmacodynamic implications of drug absorption from urinary bladder (1990) |
| Academic work | |
| Institutions | Kettering Medical Center University of Tennessee Ohio State University GTx Incorporated University of Michigan University of Alabama |
James Tilmon Dalton is an American pharmacist and drug discovery scientist. He is Executive Vice President & Provost at the University of Alabama.
Career[edit]
As a pharmacy intern and then pharmacist, Dalton worked at Kettering Medical Center. After earning his PhD, Dalton was appointed as assistant professor in the Department of Pharmaceutical Sciences at the University of Tennessee.[1] As a professor at the University of Tennessee, Dalton led the research group that first reported selective androgen receptor modulators (SARMs; enobosarm). In 1997, Dalton’s group published the first report on SARMs, which was used to research and create a class of potential drugs to treat age and disease-related muscle loss.[2] Dalton also led the research group that invented sabizabulin, a tubulin inhibitor under development for the treatment of cancer and SARS-CoV-2 (COVID-19).
From there, he was promoted to associate professor and moved to the Ohio State College (OSU) of Pharmacy faculty. Dalton was eventually promoted to full professor and Chair of the Division of Pharmaceutics.[1] While at OSU, he was elected a Fellow of the American Association of Pharmaceutical Scientists.[3] The year following his fellowship election, Dalton left OSU to become Chief Scientific Officer at GTx Incorporated.[4] Dalton left GTx in 2014 to become the Dean of Pharmaceutical Sciences at the University of Michigan.[1] The next year, he was elected a fellow of the American Association for the Advancement of Science.[5]
In 2019, Dalton was one of three UMich faculty members elected to National Academy of Medicine.[6]
In 2020, Dalton was appointed Executive Vice President & Provost at the University of Alabama in Tuscaloosa. [7]
References[edit]
- ^ a b c Fitzgerald, Rick (April 17, 2014). "James Dalton will serve as next College of Pharmacy dean". record.umich.edu. Retrieved October 31, 2019.
- ^ "U-M Pharmacy Dean James Dalton Inducted Into National Academy of Medicine". pharmacy.umich.edu. October 21, 2019. Retrieved October 31, 2019.
- ^ "2006–07 Annual Report" (PDF). pharmacy.osu.edu. p. 19. Retrieved October 31, 2019.
- ^ "James T. Dalton, Ph.D." cleancompetition.org. Archived from the original on October 31, 2019. Retrieved October 31, 2019.
- ^ Bailey, Laura (November 24, 2015). "Six U-M faculty members named AAAS fellows". record.umich.edu. Retrieved October 31, 2019.
- ^ "Three U-M faculty elected to National Academy of Medicine, one of nation's highest honors for health researchers". uofmhealth.org. October 21, 2019. Retrieved October 31, 2019.
- ^ "Dalton appointed Provost at Alabama". news.ua.edu. 18 May 2020.
External links[edit]
| International | |
|---|---|
| Academics | |
